Auna SA (AUNA) 銘柄情報

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Auna Announces 3Q24 Financial Results

Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Auna Announces Reporting Dates for Third Quarter 2024 Financial Results

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent “Lorenzo” Massart as...

Auna Announces 2Q24 Financial Results

Adjusted EBITDA increases 31% YoY, consolidating strong results OncoMexico launched in Monterrey Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Auna Announces Reporting Dates for Second Quarter 2024 Financial Results

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates...